Search details
1.
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
; 22(12): 1503-1514, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34716452
2.
Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus through Antibody-Dependent Cellular Cytotoxicity.
J Infect Dis
; 2024 Mar 13.
Article
in English
| MEDLINE | ID: mdl-38478732
3.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Article
in English
| MEDLINE | ID: mdl-34470866
4.
Soluble NS1 Antagonizes IgG- and IgA- Mediated Monocytic Phagocytosis of DENV Infected Cells.
J Infect Dis
; 228(1): 70-79, 2023 06 28.
Article
in English
| MEDLINE | ID: mdl-37103221
5.
Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections.
PLoS Pathog
; 17(1): e1009240, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33513191
6.
Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand.
Emerg Infect Dis
; 28(11): 2214-2225, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36220131
7.
Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial.
J Infect Dis
; 223(10): 1707-1716, 2021 05 28.
Article
in English
| MEDLINE | ID: mdl-32966573
8.
A Phase 1, Open-Label Assessment of a Dengue Virus-1 Live Virus Human Challenge Strain.
J Infect Dis
; 223(2): 258-267, 2021 02 03.
Article
in English
| MEDLINE | ID: mdl-32572470
9.
Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicity.
Immunology
; 164(2): 386-397, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34056709
10.
The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States.
J Infect Dis
; 221(7): 1057-1069, 2020 03 16.
Article
in English
| MEDLINE | ID: mdl-31755526
11.
Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
J Immunol
; 201(12): 3804-3814, 2018 12 15.
Article
in English
| MEDLINE | ID: mdl-30413671
12.
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques.
PLoS Pathog
; 13(8): e1006487, 2017 Aug.
Article
in English
| MEDLINE | ID: mdl-28771605
13.
Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals.
Proc Natl Acad Sci U S A
; 111(37): 13439-44, 2014 Sep 16.
Article
in English
| MEDLINE | ID: mdl-25197078
14.
Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.
J Infect Dis
; 214(7): 1001-9, 2016 Oct 01.
Article
in English
| MEDLINE | ID: mdl-27443614
15.
The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope.
J Immunol
; 188(10): 5166-76, 2012 May 15.
Article
in English
| MEDLINE | ID: mdl-22529301
16.
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study.
Nat Microbiol
; 9(5): 1356-1367, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38561497
17.
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial.
Lancet Infect Dis
; 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38679035
18.
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Structure
; 32(2): 131-147.e7, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38157856
19.
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Nat Commun
; 15(1): 200, 2024 Jan 03.
Article
in English
| MEDLINE | ID: mdl-38172512
20.
Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine.
EBioMedicine
; 97: 104815, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37793212